Page 31 - 01.pdf

DIRECTORS’ REPORT

The Directors are pleased to present their report to the members together with the audited consolidated financial

statements of AsiaMedic Limited (the “Company”) and its subsidiaries (collectively, the “Group”) and the statement of

financial position and statement of changes in equity of the Company for the financial year ended 31 December 2013.

1.

Directors

The Directors of the Company in office at the date of this report are:

Tan Wang Cheow

Non-Executive Chairman

Andi Solaiman

Non-Executive Director

Arthur Ng Boon Chye

Independent Director

Goh Kian Chee

Independent Director

Erhart Mark Allan

Independent Director

In accordance with the Article 93 of the Company’s Articles of Association, Mr Arthur Ng Boon Chye and Mr Goh

Kian Chee will retire and, being eligible, offer themselves for re-election.

2.

Arrangements to enable Directors to acquire shares and debentures

Neither at the end of nor at any time during the financial year was the Company a party to any arrangement

whose objects are, or one of whose object is, to enable the Directors of the Company to acquire benefits by

means of the acquisition of shares or debentures of the Company or any other body corporate.

3.

Directors’ interests in shares and debentures

The following Director, who held office at the end of the financial year, had, according to the register of Directors’

shareholdings required to be kept under Section 164 of the Singapore Companies Act, Chapter 50, an interest

in shares and share options of the Company and related corporations as stated below:

Direct interest

Deemed interest

Name of Director

At 1.1.2013 At 31.12.2013 At 1.1.2013 At 31.12.2013

The Company

Ordinary shares

Tan Wang Cheow

14,091,396 14,091,396

8,467,598

There was no change in any of the above-mentioned interests in the Company between the end of the financial

year and 21 January 2014.

Except as disclosed in this report, no Director who held office at the end of the financial year had interests in

shares, share options or debentures of the Company, or of related corporations, either at the beginning or at

the end of the financial year.

ASIAMEDIC LIMITED

ANNUAL REPORT 2013

29